AMPK activation by ATRA has been reported in ovarian cancer, skeletal muscle cells and endothelial cells (Lee et al., 2008; Ishijima et al., 2015; Kim et al., 2015), while the effect of ATRA on AMPK in VSMCs is unclear. Here, PRKAA1 is linked to ovarian carcinoma.